PULMONX CORPORATION Capital Expenditures
PULMONX CORPORATION (LUNG) reported Capital Expenditures of $10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- PULMONX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.00K, a 97.96% decline year-over-year.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $9.00K, a 97.01% decline year-over-year.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $13.00K, a 88.29% decline year-over-year.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $89.00K, a 78.61% decline year-over-year.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for fiscal 2025 was $452.00K, a 68.76% decline from fiscal 2024.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for fiscal 2024 was $1.45M, a 79.31% increase from fiscal 2023.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for fiscal 2023 was $807.00K, a 38.77% decline from fiscal 2022.
- PULMONX CORPORATION payments to acquire property, plant, and equipment for fiscal 2022 was $1.32M, a 64.10% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.00K 10-Q · filed 2026-08-04 | $23.00K derived: sum of 3 quarters · filed 2026-08-04 | $112.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-04 | $22.00K derived: sum of 2 quarters · filed 2026-05-04 | $111.00K derived: sum of 3 quarters · filed 2026-05-04 | $160.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $102.00K derived: sum of 2 quarters · filed 2026-03-10 | $151.00K derived: sum of 3 quarters · filed 2026-08-04 | $452.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $138.00K derived: sum of 2 quarters · filed 2026-08-04 | $439.00K 10-Q · filed 2025-11-12 | $550.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $350.00K 10-Q · filed 2026-08-04 | $461.00K derived: sum of 3 quarters · filed 2026-08-04 | $877.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $301.00K 10-Q · filed 2026-05-04 | $412.00K derived: sum of 2 quarters · filed 2026-05-04 | $828.00K derived: sum of 3 quarters · filed 2026-05-04 | $1.30M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $527.00K derived: sum of 2 quarters · filed 2026-03-10 | $996.00K derived: sum of 3 quarters · filed 2026-03-10 | $1.45M 10-K · filed 2026-03-10 |
| 2024-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $885.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.34M 10-Q · filed 2025-11-12 | $1.54M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $920.00K 10-Q · filed 2025-08-01 | $1.12M derived: sum of 3 quarters · filed 2025-08-01 | $1.61M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $451.00K 10-Q · filed 2025-05-02 | $651.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.14M derived: sum of 3 quarters · filed 2025-05-02 | $1.20M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $692.00K derived: sum of 2 quarters · filed 2025-02-25 | $746.00K derived: sum of 3 quarters · filed 2025-02-25 | $807.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $546.00K derived: sum of 2 quarters · filed 2024-11-01 | $607.00K 10-Q · filed 2024-11-01 | $783.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $115.00K 10-Q · filed 2024-08-02 | $291.00K derived: sum of 3 quarters · filed 2024-08-02 | $570.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $61.00K 10-Q · filed 2024-05-03 | $237.00K derived: sum of 2 quarters · filed 2024-05-03 | $516.00K derived: sum of 3 quarters · filed 2024-05-03 | $815.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $455.00K derived: sum of 2 quarters · filed 2024-02-27 | $754.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.32M 10-K · filed 2024-02-27 |
| 2022-09-30 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $578.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.14M 10-Q · filed 2023-11-03 | $2.29M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $863.00K 10-Q · filed 2023-08-04 | $2.01M derived: sum of 3 quarters · filed 2023-08-04 | $3.63M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $564.00K 10-Q · filed 2023-05-08 | $1.71M derived: sum of 2 quarters · filed 2023-05-08 | $3.33M derived: sum of 3 quarters · filed 2023-05-08 | $3.99M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.77M derived: sum of 2 quarters · filed 2023-03-01 | $3.43M derived: sum of 3 quarters · filed 2023-03-01 | $3.67M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.28M derived: sum of 2 quarters · filed 2022-11-08 | $2.52M 10-Q · filed 2022-11-08 | $3.22M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $903.00K 10-Q · filed 2022-08-08 | $1.60M derived: sum of 3 quarters · filed 2022-08-08 | $1.67M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $242.00K 10-Q · filed 2022-05-09 | $935.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.01M derived: sum of 3 quarters · filed 2022-05-09 | $1.07M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $769.00K derived: sum of 2 quarters · filed 2022-03-01 | $830.00K derived: sum of 3 quarters · filed 2022-03-01 | $911.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $137.00K derived: sum of 2 quarters · filed 2021-11-09 | $218.00K 10-Q · filed 2021-11-09 | $439.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $142.00K 10-Q · filed 2021-08-10 | $363.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $81.00K 10-Q · filed 2021-05-12 | $302.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $720.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $499.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $316.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |